Patents
Patents for C07D 253 - Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group (2,967)
08/2011
08/11/2011CA2789279A1 1,2,4-triazine-4-amine derivatives
08/09/2011CA2422589C Pyridazinone and triazinone compounds and use thereof as pharmaceutical preparations
08/04/2011US20110190496 FUSED BICYCLIC mTOR INHIBITORS
08/03/2011CN1890218B Tubulin inhibitors
08/02/2011US7989451 Tricyclic 1,2,4-triazine oxides and compositions for therapeutic use in cancer treatments
07/2011
07/28/2011US20110183983 Heterocyclic compound as protein kinase inhibitor
07/28/2011US20110183972 Aromatic ring fused triazine derivatives and uses thereof
07/26/2011CA2445344C Heterocyclic compound derivatives and medicines
07/21/2011US20110178087 Compositions and Their Use as Anti-Tumor Agents
07/20/2011EP2345640A1 Adamantyl- acetamide derivatives as inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
07/20/2011CN102127056A Tubulin inhibitors
07/20/2011CN101328154B 3-alcoxymethyl amidine-1,2,4-benzotriazin derivates, preparation and use thereof
07/19/2011US7981900 2-phenyl pyrimidines which are tubulin inhibitors
07/13/2011EP2342181A1 Novel urea and thiourea derivatives
07/12/2011US7977331 Tetracyclic fused heterocyclic compound and use thereof as HCV polymerase inhibitor
06/2011
06/28/2011US7968707 Reacting an amino, hydroxy substituted amide with a heterocyclic substituted carboxylic acid to produce (2S,3S,5S)-2-(2,6-Dimethylphenoxyacetyl) amino-3-hydroxy-5-[2S-1-imidazolidin-2-onyl)-3-methyl-butanoyl] amino-1,6-diphenylhexane; inhibitors of HIV infection
06/21/2011US7964204 Isoxazolines for controlling invertebrate pests
06/15/2011CN102093363A Pyrrolo-triazine aniline compounds useful as kinase inhibitors
06/07/2011CA2483164C Pyrrolo-triazine aniline compounds useful as kinase inhibitors
06/01/2011EP1379510B1 Aryl and heteroaryl urea chk1 inhibitors for use as radiosensitizers and chemosensitizers
06/01/2011CN102083814A Salts of 2-fluoro-n-methyl-4-[7-(quinolin-6-yl-methyl)- imidazo[1,2-b][1,2,4]triazin-2-yl]benzamide and processes related to preparing the same
06/01/2011CN102083803A Oxo-heterocyclic substituted carboxylic acid derivates and the use thereof
05/2011
05/26/2011WO2011061243A1 Heterocyclic antiviral compounds
05/26/2011US20110123489 Heterocyclic antiviral compounds
05/26/2011CA2778206A1 Heterocyclic antiviral compounds
05/25/2011EP2325169A2 Lisofylline analogues and their pharmeacuetical uses
05/25/2011CN1578663B Inhibitors of histone deacetylase
05/25/2011CN102070545A Method for preparing lamotrigine
05/18/2011CN102060782A Method for preparing chloropyrimidines or analogues thereof
05/12/2011WO2011005909A3 Process for substituted 3-amino-5-oxo-4,5-dihydro-[1,2,4]triazines
05/11/2011EP2318374A2 Insecticidal benzenedicarboxamide derivative
05/05/2011WO2011005515A3 Bis-trifluoromethyl honokiol analogs and their use in treating cancers
05/05/2011WO2010115098A3 Palladium-catalyzed ortho-fluorination
05/03/2011CA2439709C Aryl and heteroaryl urea chki inhibitors for use as radiosensitizers and chemosensitizers
04/2011
04/28/2011US20110098467 Pyrrolo-triazine aniline compounds useful as kinase inhibitors
04/27/2011EP1989190B1 Triazine 11-beta hydroxysteroid dehydrogenase type i inhibitors
04/26/2011US7932388 Intermediates of active esters for peptide synthesis, labeling, analysis; purity
04/21/2011WO2011047192A2 Protected amine labels and use in detecting analytes
04/14/2011WO2011042522A1 Rubber composition comprising a 1, 2, 4 -triazine
04/14/2011WO2011042521A1 1, 2, 4 - triazine suitable as a vulcanization accelerator and method for producing same
04/14/2011US20110086818 Methods, compositions, and kits for treating pain and pruritus
04/12/2011US7923554 HIV inhibiting 1,2,4-triazin-6-one derivatives
04/05/2011US7919528 Antibiotic; bactericides
03/2011
03/31/2011WO2011004195A3 Cyclic triazo sodium channel blockers
03/30/2011EP2300455A2 Salts of 2-fluoro-n-methyl-4-[7-(quinolin-6-yl-methyl) - imidazo [1, 2-b] [1, 2, 4] triazin-2-yl] benzamide and processes related to preparing the same
03/17/2011US20110065918 New phenylalanine derivatives
03/16/2011EP1448535B1 Benzamide and heteroarylamide as p2x7 receptor antagonists
03/15/2011US7906235 Pentacyclic anion salts or tetrazapentalene derivatives and their uses as ionic conducting materials
03/02/2011EP2289894A2 Pyrrolo-triazine compounds useful as kinase inhibitors
02/2011
02/24/2011WO2010129211A3 Preparation of decitabine
02/24/2011US20110045974 Substituted Triazinylmethyl Sulfonamides
02/15/2011US7888356 Antibiotics containing borinic acid complexes and methods of use
02/10/2011US20110034450 Oxo-heterocyclic substituted carboxylic acid derivatives and the use thereof
02/10/2011CA2770471A1 Processes for the preparation of vardenafil
02/09/2011EP1689715B1 Tubulin inhibitors
02/03/2011US20110028479 Substituted pyrrolotriazines and their use
02/03/2011US20110027800 Derivatives of 1,2-dihydro-7-hydroxyquinolines Containing Fused Rings
02/02/2011EP1288205B1 Novel phenylalanine derivatives
01/2011
01/26/2011EP2277865A1 Phenyl-substituted 6-ring nitrogen-heterocycles as microtubule polymerisation inhibitors
01/25/2011US7875612 Folate mimetics and folate-receptor binding conjugates thereof
01/18/2011US7872125 1-Methyl,3-((1,3-dichloro-phenyl)-carbonylamino-(1-carboxy- eth-1,2-ylene)-(1,4-phenylene)-)quinazolin-2,4-dione; inhibiting the adhesion of VCAM-1 (vascular cellular adhesion molecules-1) to alpha-4 integrin; antiinflammatory agents; cardiovascular disorders; multiple sclerosis; antiarthritic agent
01/13/2011WO2011005909A2 Process for substituted 3-amino-5-oxo-4,5-dihydro-[1,2,4]triazines
01/13/2011WO2011005515A2 Bis-trifluoromethyl honokiol analogs and their use in treating cancers
01/13/2011WO2011004196A1 Cyclic triazo sodium channel blockers
01/13/2011WO2010012442A8 Insecticidal benzenedicarboxamide derivative
01/13/2011US20110009413 Cyclic triazo and diazo sodium channel blockers
01/13/2011CA2767298A1 Cyclic triazo sodium channel blockers
01/13/2011CA2767296A1 Cyclic triazo sodium channel blockers
01/13/2011CA2764173A1 Process for substituted 3-amino-5-oxo-4,5-dihydro-[1,2,4]triazines
01/11/2011US7868000 Aspartyl protease inhibitors
01/11/2011CA2453974C 4-(benzylideneamino)-3-(methylsulfanyl)-4h-1,2,4-triazin-5-one derivatives having a pde iv-inhibiting and tnf-antagonistic action for the treatment of heart diseases and allergies
01/05/2011EP2268625A1 Oxo-heterocyclic substituted carboxylic acid derivates and the use thereof
12/2010
12/30/2010US20100330069 Heterocyclic compounds and methods of use
12/30/2010US20100330030 Vasculostatic Agents and Methods of Use Thereof
12/29/2010WO2010149044A1 Micromolecular benzotriazine compounds, compositions and uses thereof
12/29/2010EP2266965A1 Methods for Isolating Crystalline Form I of 5-Azacytidine
12/29/2010EP2265626A2 Nucleotide analogues with quaternary carbon stereogenic centers and methods of use
12/28/2010US7858641 melanocortin-4 receptor (MC4-R) agonists such as (3R,5S)-N-(2-{2-[2-fluoro-4-(methyloxy)phenyl]ethyl}-1-oxo-1,2-dihydroisoquinolin-6-yl)-3,5-dimethyl-N'-[(1S,2S,3S,5R)-2,6,6-trimethylbicyclo[3.1.1]hept-3-yl]piperazine-1-carboximidamide, used for the treatment of obesity or diabetes
12/28/2010US7858631 such as (3R,5S)-N-(3-{2-[2-fluoro-4-(methyloxy)phenyl]ethyl}-4-oxo-3,4-dihydropyrido[2,3-d]pyrimidin-7-yl)-3,5-dimethyl-N'-[(1S,2S,3S,5R)-2,6,6-trimethylbicyclo[3.1.1]hept-3-yl]piperazine-1-carboximidamide, used as melanocortin-4 receptor (MC4-R) agonists, for the treatment of obesity or diabetes
12/23/2010WO2010145790A1 Propargyloxybenzamide derivatives
12/15/2010EP1866292B1 Tricyclic 1,2,4-triazine oxides and compositions therefrom for therapeutic use in cancer treatments
12/15/2010CN101918378A Cyclic triazo and diazo sodium channel blockers
12/09/2010US20100311755 1,2,4,-triazin-3,5-dione compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor
12/07/2010US7846925 such as 5-(1,3-benzodioxol-5-ylmethylene)-1,3-thiazolidine-2,4-dione, used for the treatment and/or prophylaxis of autoimmune, cardiovascular or neurodegenerative disorders, inflammatory or kidney diseases, bacterial or viral infections, platelet aggregation, cancer, transplant rejection or lung injuries
12/07/2010CA2374995C Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation
12/02/2010US20100305078 Metallo-oxidoreductase inhibitors using metal binding moieties in combination with targeting moieties
12/02/2010US20100303905 Orally Disintegrating Tablet Compositions of Lamotrigine
12/01/2010CN101899016A New technology for recycling metribuzin methylate mother liquor
11/2010
11/30/2010US7842805 1-arylamino-phthalazines such as 5-Fluorophthalazin-1-yl)-(4-methoxyphenyl)-methyl-amine or 4-arylamino-benzo[d][1,2,3]triazines such as Benzo[d][1,2,3]triazin-4-y1-(4-methoxy-pheny1)-methyl-amine, used as anticarcinogenic agents or for the treatment of psoriasis, autoimmune diseases and fungi infections
11/25/2010US20100298331 Triazinone and diazinone derivatives useful as hsp90 inhibitors
11/24/2010EP1280764B1 Inhibitors of histone deacetylase
11/18/2010WO2010132691A1 Oligomer-containing substituted aromatic triazine compounds
11/18/2010US20100292180 Pharmaceutical Compositions Comprising Crystal Forms of 5-Azacytidine
11/18/2010CA2760219A1 Oligomer-containing substituted aromatic triazine compounds
11/17/2010EP2251334A1 Labeling reagents and labeled analytes
11/17/2010EP2251332A1 The aromatic ring triazine derivatives and the uses thereof
11/16/2010US7834178 Triazine 11-beta hydroxysteroid dehydrogenase type 1 inhibitors
11/11/2010WO2010129211A2 Preparation of decitabine
11/04/2010US20100278811 Vasculostatic agents and methods of use thereof
10/2010
10/28/2010WO2009127338A8 Oxo-heterocyclic substituted carboxylic acid derivates and the use thereof
1 2 3 4 5 6 7 8 9 10 11 12 13 14 ... 30